ScholarIQanswers from OpenAlex

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

PaperCitations, authors & open-access status

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases have?

ScholarIQcitation count

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases has 141 citations in the OpenAlex counts ScholarIQ stores.

When was Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases published?

ScholarIQyear

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases has 2017 year in the ScholarIQ index.

What is the open-access status of Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases?

ScholarIQoa status

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases has closed oa status in the ScholarIQ index.

What is the DOI of Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases?

ScholarIQdoi

The DOI for Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases is on the source record.

What is the PMID of Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases?

ScholarIQpmid

The PMID for Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases is on the source record.

What is the OpenAlex record for Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases?

ScholarIQopenalex

The OpenAlex for Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial